
### [MONDO:0000105](http://purl.obolibrary.org/obo/MONDO_0000105)
**Label:** anemia, nonspherocytic hemolytic

**Subclasses:** [MONDO:0010480](http://purl.obolibrary.org/obo/MONDO_0010480) (anemia, nonspherocytic hemolytic, due to G6Pd deficiency), [MONDO:0008790](http://purl.obolibrary.org/obo/MONDO_0008790) (anemia, nonspherocytic hemolytic, possibly due to defect 1N porphyrin metabolism), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0008789](http://purl.obolibrary.org/obo/MONDO_0008789) (anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane), 

**Corr. equiv. classes:** [OMIM:206300](http://purl.obolibrary.org/obo/OMIM_206300), [OMIM:300908](http://purl.obolibrary.org/obo/OMIM_300908), [OMIM:206400](http://purl.obolibrary.org/obo/OMIM_206400), [Orphanet:466026](http://www.orpha.net/ORDO/Orphanet_466026), 

**Class expressions from DL-Learner:**

- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0004297](http://purl.obolibrary.org/obo/HP_0004297) (Abnormality of the biliary system) 62.50%
- [HP:0001930](http://purl.obolibrary.org/obo/HP_0001930) (Nonspherocytic hemolytic anemia) and [HP:0010472](http://purl.obolibrary.org/obo/HP_0010472) (Abnormality of the heme biosynthetic pathway) 62.50%
- [HP:0001930](http://purl.obolibrary.org/obo/HP_0001930) (Nonspherocytic hemolytic anemia) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 62.50%
- [HP:0003163](http://purl.obolibrary.org/obo/HP_0003163) (Elevated urinary delta-aminolevulinic acid) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 62.50%


